Clinical case of gastroesophageal reflux disease exacerbation in a middle-aged patient with COVID-19

Larina V.N.; Ryzhikh A.A.; Karpenko D.G.; Taraskova K.I.; Oynotkinova O.Sh.

doi:https://doi.org/10.17116/dokgastro20211003170

Larina V.N.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia

ORCID: 0000-0001-7825-5597

Ryzhikh A.A.

Pirogov Russian National Research Medical University

Karpenko D.G.

Pirogov Russian National Research Medical University

Taraskova K.I.

Pirogov Russian National Research Medical University

Oynotkinova O.Sh.

Research Institute of Health Organization and Medical Management;
Central State Medical Academy of the Office of the President of the Russian Federation

ORCID: 0000-0002-9856-8643

Clinical case of gastroesophageal reflux disease exacerbation in a middle-aged patient with COVID-19

Authors:

Larina V.N., Ryzhikh A.A., Karpenko D.G., Taraskova K.I., Oynotkinova O.Sh.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2021;10(3): 70‑76

DOI: 10.17116/dokgastro20211003170

Read: 4528 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Larina VN, Ryzhikh AA, Karpenko DG, Taraskova KI, Oynotkinova OSh. Clinical case of gastroesophageal reflux disease exacerbation in a middle-aged patient with COVID-19. Russian Journal of Evidence-Based Gastroenterology. 2021;10(3):70‑76. (In Russ.)
https://doi.org/10.17116/dokgastro20211003170

Подписка 2026 Доказательная гастроэнтерология (Russian Journal of Evidence-Based Gastroenterology)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To describe COVID-19 influence on gastroesophageal reflux disease (GERD) exacerbation using clinical case.

MAIN POINTS

COVID-19 infection remains an urgent problem for modern medicine due to its high contagiousness and rapid distribution among the working population. We presented a clinical case of a 49-year-old female patient with respiratory complaints and extraesophageal manifestations of GERD.

CONCLUSION

This clinical case showed that clinicians should consider various mechanisms of respiratory symptoms, which becomes exceptionally relevant during the COVID-19 pandemic. The development of atypical symptoms in a patient of working age without concomitant pathology causes difficulties in early diagnosis and timely treatment, in contrast to comorbid elderly and senile patients. Several mechanisms led to an exacerbation of GERD with the development of wheezing. Therefore, a clinician should meticulously take a medical history, form a trusting relationship with a patient, detect and correct early signs of anxiety and depression with a multidisciplinary team.

Keywords:

gastroesophageal reflux disease

COVID-19

SARS-CoV-2

wheezing

Authors:

Larina V.N.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia

ORCID: 0000-0001-7825-5597

Ryzhikh A.A.

Pirogov Russian National Research Medical University

Karpenko D.G.

Pirogov Russian National Research Medical University

Taraskova K.I.

Pirogov Russian National Research Medical University

Oynotkinova O.Sh.

Research Institute of Health Organization and Medical Management;
Central State Medical Academy of the Office of the President of the Russian Federation

ORCID: 0000-0002-9856-8643

Received:

08.05.2021

Accepted:

03.07.2021

Close metadata

References:

Chen J, Brady P. Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment. Gastroenterology Nursing. 2019; 42(1):20-28. https://doi.org/10.1097/SGA.0000000000000359
Chatila AT, Nguyen MTT, Krill T, Roark R, Bilal M, Reep G. Natural history, pathophysiology and evaluation of gastroesophageal reflux disease. Disease-a-Month. 2020;66(1):100848. https://doi.org/10.1016/j.disamonth.2019.02.001
Pustorino S, Guerrisi O, Calipari G, Federico G, Iannì G, Scarpignato EM, Pizzimenti C, Corona G, Martinez P, Migliorato D. Psycho-emotional distress and gastroesophageal reflux syndrome. Minerva Gastroenterologica e Dietologica. 1991;37(1):1-9.
Maev IV, Andreev DN, Kucheryavyy YuA, Shaburov RI. Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection. Terapevticheskij arhiv. 2019;91(8):4-11. (In Russ.). https://doi.org/10.26442/00403660.2019.08.000387
Macedo C, Almeida N. Endoscopy in Extraesophageal Manifestations Secondary to Gastroesophageal Reflux Disease: Why Do We Insist? GE Portuguese Journal of Gastroenterology. 2020;27(5):302-303. https://doi.org/10.1159/000507637
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Journal of Clinical Virology. 2020;127:104371. https://doi.org/10.1016/j.jcv.2020.104371
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science. 2020; 12(1):8. https://doi.org/10.1038/s41368-020-0074-x
Vremennye metodicheskie rekomendacii. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19). Versiya 4 ot 27.03.20. M.: Ministerstvo zdravoohraneniya Rossijskoj Federacii; 2020. Accessed April 20, 2020. (In Russ.). https://static-3.rosminzdrav.ru/system/attachments/attaches/000/049/877/original/COVID19_recomend_v4.pdf
Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, Hao SR, Jia HY, Cai H, Zhang XL, Yu GD, Xu KJ, Wang XY, Gu JQ, Zhang SY, Ye CY, Jin CL, Lu YF, Yu X, Yu XP, Huang JR, Xu KL, Ni Q, Yu CB, Zhu B, Li YT, Liu J, Zhao H, Zhang X, Yu L, Guo YZ, Su JW, Tao JJ, Lang GJ, Wu XX, Wu WR, Qv TT, Xiang DR, Yi P, Shi D, Chen Y, Ren Y, Qiu YQ, Li LJ, Sheng J, Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-1009. https://doi.org/10.1136/gutjnl-2020-320926
Pike BL, Porter CK, Sorrell TJ, Riddle MS. Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis. American Journal of Gastroenterology. 2013;108(10): 1558-1564. https://doi.org/10.1038/ajg.2013.147
Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. American Journal of Gastroenterology. 2012;107(6):891-899. https://doi.org/10.1038/ajg.2012.102
Singhania N, Bansal S, Singhania G. An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19). American Journal of Medicine. 2020;133(7):365-366. https://doi.org/10.1016/j.amjmed.2020.03.026
Sorokin MYu, Kasyanov ED, Rukavishnikov GV, Makarevich OV, Neznanov NG, Lutova NB, Maso G.E. The structure of anxious experiences associated with the spread of COVID-19: data from an online survey. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta. 2020;3:77-84. (In Russ.). https://doi.org/10.24075/vrgmu.2020.030
Choi EPH, Hui BPH, Wan EYF. Depression and Anxiety in Hong Kong during COVID-19. International Journal of Environmental Research and Public Health. 2020;17(10):3740. https://doi.org/10.3390/ijerph17103740
Trofimov VI, Bezrukov YuN. Psychosomatic aspects in the treatment of gastroesophageal reflux disease. Arhiv’ vnutrennej mediciny. 2015;5:55-61. (In Russ.).
Nazariev NV, Chakhnashvili ML, Ivanov DV, Lishchuk AN, Koltunov AN. Psychosomatic disorders after an outbreak of coronavirus infection (clinical cases). Vestnik novyh medicinskih tekhnologij. Elektronnoe izdanie. 2020;14(3):7-16. (In Russ.). https://doi.org/10.24411/2075-4094-2020-16640
Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS, Reiersen M. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020;324(22):2292-2300. https://doi.org/10.1001/jama.2020.22760
Yurenev GL, Samsonov AA, Yureneva-Thorzhevskaya TV, Maev IV. Bronchoobstructive syndrome in patients with gastroesophageal reflux disease: an extraesophageal manifestation of the disease or bronchial asthma? Consilium medicum. 2014;16(8):33-38. (In Russ.).
Long L, Lai K. Characteristics of Chinese chronic cough patients. Pulmonary Pharmacology and Therapeutics. 2019;57:101811. https://doi.org/10.1016/j.pupt.2019.101811
Sandu M, Barboi O, Drug V. Gastroesophageal reflux disease in respiratory disorders: P1299 Esophageal, Gastric and Duodenal Disorders. Journal of Gastroenterology and Hepatology. 2013;28: 513-514.